Revonto
Revonto is a medication designed for the management of malignant hyperthermia (MH) crises, characterized by fulminant hypermetabolism of skeletal muscle, and is suitable for patients of all ages. It is also indicated for preoperative and postoperative use to help prevent or lessen the development of clinical signs in individuals deemed susceptible to MH.
The administration of Revonto, which contains dantrolene sodium, must be accompanied by appropriate supportive measures and individualized patient care. Important safety information highlights the necessity of monitoring vital signs and being aware of potential adverse reactions, as well as the importance of adhering to standard malignant hyperthermia protocols to mitigate risks associated with the treatment.
Generated from the website